7.24
-0.14(-1.90%)
Currency In USD
| Previous Close | 7.38 |
| Open | 7.49 |
| Day High | 7.49 |
| Day Low | 7.24 |
| 52-Week High | 25 |
| 52-Week Low | 4.11 |
| Volume | 12,106 |
| Average Volume | 78,286 |
| Market Cap | 137.75M |
| PE | -2.93 |
| EPS | -2.47 |
| Moving Average 50 Days | 7.82 |
| Moving Average 200 Days | 7.82 |
| Change | -0.14 |
Data not available
NeOnc Technologies Global Patent Portfolio Covers Core Pipeline Across All Major Pharmaceutical Markets
GlobeNewswire Inc.
Apr 15, 2025 12:05 PM GMT
-- 176 Patents Issued and Outstanding Reinforces NeOnc’s Competitive Position -- CALABASAS, Calif., April 15, 2025 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (NASDAQ: NTHI), a biopharmaceutical company focused on the development of novel
NeOnc Technologies Holdings, Inc. Executive Chairman, Amir Heshmatpour, Assumes Expanded Leadership Role as Company’s New President
GlobeNewswire Inc.
Apr 10, 2025 12:05 PM GMT
CALABASAS, Calif., April 10, 2025 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (NASDAQ: NTHI), a clinical-stage biopharmaceutical company focused on innovative treatments for central nervous system (CNS) cancers and disorders, today announ
NeOnc Technologies Announces Near Completion of Phase I Enrollment for NEO212 Brain Cancer Therapy
GlobeNewswire Inc.
Apr 08, 2025 8:05 PM GMT
CALABASAS, Calif., April 08, 2025 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (NASDAQ: NTHI), a clinical-stage biopharmaceutical company focused on innovative treatments for central nervous system (CNS) cancers and disorders, today announ